期刊文献+

B型钠尿肽前体(NT—proBNP)与C反应蛋白(C-reactionprotein,CRP)在诊断HF中的应用价值 被引量:1

Clinical Value of Combined Test of NT-proBNP and CRP in the Patients with Congestive Heart Failure
下载PDF
导出
摘要 目的 研究B型钠尿肽前体(NT—proBNP)与C反应蛋白(c—reactionprotein,CRP)联合检测在诊断充血性心力衰竭中的应用价值及其对心功能的评价作用。方法选择慢性充血性心力衰竭患者60例,测定血清NT—proBNP、CRP浓度分析其水平变化。结果NYHA心功能Ⅰ,Ⅱ、Ⅲ、Ⅳ级的患者,NT—proBNP分别为(133.3±100.1)、(542.2±2024)、(754.3±207.9)、(1241.2±403.5)ng/L,CRP分别为(12.4±4.5)(16.8±4.7)、(23.4±5.2)、(32.2±5.7)mg/L,心功能越差,NT—proBNP、CRP越高。结论检测血浆NT—proBNP、CRP的水平对HF的诊断、严重程度评价有重要价值。 Objectlve To evaluate the value of NT-proBNP with CRP in patients with heart failure (HF). Methods The blood NT-proBNP and CRP were determined in 60 patients with HF,to analyze the level of it vary Results The NT-proBNP level of patients with NYHA cardiac function Ⅰ, Ⅱ, Ⅲ, Ⅳ ,it separate (133.3±100.1),(542.2±202.4) ,(754.3±207.9) ,(1241. 2 ±403.5) ng/L, and CRP is the one from the other( 12.4±4.5),(16.8±4.7) ,( 23.4 ±5.2) ,( 32.2±5.7) mg/L,the cardiac function was worse and NT-proBNP,CRP were higher. Conclusion to detect NT-proBNP combined with CRP leves have important value of diagnosis and severes degree of it.ative feelings such as tension and anxiety, improve patient care and satisfaction are conducive to patient recovery.
作者 刘巧 LIU qiao (Department of Clinical Laboratory, Hui Zhou City People's Hosipital,Huizhou 516000,China)
出处 《医学信息》 2010年第5期1330-1331,共2页 Journal of Medical Information
关键词 B型钠尿肽前体 C反应蛋白 心力衰竭 NT-pro BNP C-reaction Protein Heart Failure
  • 相关文献

参考文献1

二级参考文献17

  • 1Nakamura M, Endo H, Nasu M,et al. Value of plasma B - type natriuretic peptide measurement for heart disease screening in a Japanese population.Heart, 2002, 87:131. 被引量:1
  • 2Davis M, Espiner E, Richards G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea, Lancet, 1994, 343:440. 被引量:1
  • 3Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriumetic peptide in the emergency diagnosis of heart failure,N Engl J Med, 2002, 347:161. 被引量:1
  • 4Harrison A, Morrison LK, Krishnaswamy P, et al, B- type natriuretic peptide (BNP) predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med, 2002,39:131. 被引量:1
  • 5Berger R, Huelsman M, Strecker K, et al. B - type natriuretic peptide predicts sudden death in patients with chronic heart failure,Circulation, 2002,105(20) :2392. 被引量:1
  • 6Van Cheng BS, Kazanagra R, Gercia A,et al, A rapid bedside test for B-type petide predicts treatment outcomes in patients admitted for decompensated heart faihrre:a pilot study,J Am Coll Cardiol, 2001, 37:386. 被引量:1
  • 7Kazanegra R, Chen V, Gatrcia A, et al, A rapid test fof B- type natriuretic peptide(BNP)correlates with falling wedge pressures in patients treated for decompensated heart failure:a pilot stddy, J Card Failing, 2001, 7:21. 被引量:1
  • 8Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide(N- BNP) concentrations. Lancet, 2000, 355:1126. 被引量:1
  • 9Latini R, Masson S, Anand l,et al. Effects of valsamtan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic beart failure:the Valsartan Heart Failure Trial( Val - HeFT). Circulation, 2002, 106(19) :2454. 被引量:1
  • 10Maisel A, B - type natriuretic peptide levels:diagnostic and prognostic in congestive heart failure: what's next ? Circulation, 2002,105(20):2328. 被引量:1

共引文献7

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部